Company profile
AirSculpt Technologies, Inc.
NASDAQ: AIRS · Healthcare · Medical - Care Facilities
#308 of 1,418 Healthcare companies by revenue30th-percentile growth
EA Score
58CFH 69DQ 51GM 40SS 54
v0.1 · 65/100 weight · provisional
↑ workforce scale, return on assets · ↓ listing tenure, disclosure history
Methodology →Revenue TTM
$151.8M
Rev growth YoY (TTM)
-11.8%
Net income (FY)
-$11.7M
Employees
347
as of 2026-08-12
Market cap
$226.8M
as of 2026-08-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$151.8M$151.8M2025
Net income-$11.7M-$11.7M2025
Operating income-$11.6M-$11.6M2025
Total assets$187.3M$187.3M2025
Liabilities$99.6M$99.6M2025
Equity$87.7M$87.7M2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY21
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Reportable100%
By geography
Non-US100%
The read
What is AirSculpt Technologies, Inc.’s revenue?
AirSculpt Technologies, Inc. booked $151.8M in FY2025 revenue, contracting 16% year over year — slower than 70% of Healthcare companies we track, at a -7.7% net margin.
Peers · Healthcare
MariMed Inc.66BLiquidia Corporation58CHeron Therapeutics, Inc.58CMacroGenics, Inc.54DNeuronetics, Inc.59CElite Pharmaceuticals, Inc.77B+Neighbors
Miami-Dade →Key facts
CEOYogi Jashnani
SectorHealthcare
IndustryMedical - Care Facilities
HeadquartersMiami Beach, FL
ExchangeNASDAQ: AIRS
Employees347
IPO date2021-10-29
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.